Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 08, 2020

BUY
$14.45 - $24.69 $214,177 - $365,955
14,822 New
14,822 $266,000
Q3 2019

Nov 08, 2019

SELL
$25.47 - $33.37 $396,338 - $519,270
-15,561 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$29.96 - $38.87 $466,207 - $604,856
15,561 New
15,561 $515,000

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.02B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Ontario Teachers Pension Plan Board Portfolio

Follow Ontario Teachers Pension Plan Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ontario Teachers Pension Plan Board, based on Form 13F filings with the SEC.

News

Stay updated on Ontario Teachers Pension Plan Board with notifications on news.